Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
19 participants
OBSERVATIONAL
2019-06-20
2020-04-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will also gather information from volunteers regarding a woman's health during her pregnancy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home Pregnancy Test Study on BioBank Samples
NCT04610632
Clearblue Home Pregnancy Test Consumer Study
NCT01279486
Early Pregnancy Sample Collection Study
NCT01577147
Urine Sample Collection From Non Pregnant Peri and Post-menopausal Women
NCT02945189
Continuous Sample Collection Study
NCT03719846
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Urine samples will be delivered to SPD either via post, or by hand and form part of the SPD BioBank. All urine samples will be stored and used for research or product validation purposes.
The study will also gather information from volunteers regarding a woman's health during her pregnancy, including any bleeding, discharge, discomfort, contractions/ Braxton Hicks via the use of a daily diary.
Pregnancy outcome details including labour specifics and birth outcomes such as birth date, weight, and sex of the baby will be obtained 4-6 weeks after the volunteer has given birth via email correspondence between the volunteer and study co-ordinator.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
urine sample collection
no drug/devise intervention. sample collection study only
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* complication that would affect the ability to participate in the study
* more than 38 weeks pregnant
* Have a planned caesarean section
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SPD Development Company Limited
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Johnson
Role: STUDY_DIRECTOR
SPD Development company Ltd.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SPD Development Company Ltd
Bedford, Bedfordshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PROTOCOL-1095
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.